Literature DB >> 8721656

Secular trends in the prevalence of atrial fibrillation: The Framingham Study.

P A Wolf1, E J Benjamin, A J Belanger, W B Kannel, D Levy, R B D'Agostino.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8721656     DOI： 10.1016/s0002-8703(96)90288-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  91 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 2.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

3.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

4.  Effectiveness and safety of therapy with vitamin K antagonists in Italian patients aged 80 years or older: a multicentre retrospective study comparing the Zeus algorithm with the PARMA algorithm or manual therapy.

Authors:  Arturo Cafolla; Luigia Manisco; Erminia Baldacci; Alessandro Porcu; Melissa Campanelli; Maria Concetta Cursano; Enza Rossi; Francesco Dragoni; Roberto Foà
Journal:  Drugs Aging       Date:  2015-03       Impact factor: 3.923

5.  Atrial fibrillation: now one of the most common causes for hospitalization.

Authors:  Joseph S Alpert
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

6.  Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.

Authors:  Jonathan P Piccini; Xiaojuan Mi; Tracy A DeWald; Alan S Go; Adrian F Hernandez; Lesley H Curtis
Journal:  Heart Rhythm       Date:  2012-04-24       Impact factor: 6.343

Review 7.  Current perceptions of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Cardiol Clin       Date:  2009-02       Impact factor: 2.213

8.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

9.  Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.

Authors:  Wanwarat Ananthapanyasut; Sirikarn Napan; Earl H Rudolph; Tasma Harindhanavudhi; Husam Ayash; Kelly E Guglielmi; Edgar V Lerma
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 8.237

10.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.